English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAbbott healthcare

    Abbott Healthcare

    Jump to
    • Implementing corrective actions at Goa unit; stopped Digene production at the facility, says Abbott

      Implementing corrective actions at Goa unit; stopped Digene production at the facility, says Abbott

      Earlier this month, regulator DCGI cautioned against the consumption of Digene Gel citing safety concerns even as the drug maker recalled several batches of the medicine manufactured at the Goa facility.

    • AstraZeneca Pharma, Abbott Healthcare terminate distribution agreements for diabetes drug in India

      AstraZeneca Pharma, Abbott Healthcare terminate distribution agreements for diabetes drug in India

      "AstraZeneca India and Abbott have mutually terminated the distribution agreement on May 27, 2021," AstraZeneca India said in a regulatory filing.

    • AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug

      AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug

      Dapagliflozin, an innovative Type 2 diabetes medicine, is AstraZeneca Pharma's leading diabetes medicine.

    • Abbott gets nod to withdraw Xience Alpine stent from India

      Abbott gets nod to withdraw Xience Alpine stent from India

      The company had earlier this month approached the National Pharmaceuticals Pricing Authority (NPPA) to discontinue Xience Alpine stent following capping of prices of medical devices by the drug price regulator.

    • Drug firms face NPPA action for violating price control norm

      Drug firms face NPPA action for violating price control norm

      In a notification issued , the National Pharmaceutical Pricing Authority (NPPA) said that various companies have launched formulations by altering a scheduled formulation with strength dosage other than as specified in the Drugs Price Control Order (DPCO) 2013.

    • Centre ban on FDCs: P&G, Glenmark, Reckitt too get HC relief

      Centre ban on FDCs: P&G, Glenmark, Reckitt too get HC relief

      Justice Rajiv Sahai Endlaw said "same orders" would be passed in respect of the five companies which also included Alembic Pharmaceuticals and Piramal Enterprises Ltd as was passed yesterday and day before in the case of pharma majors Pfizer, Abbott Healthcare and Macleods Pharmaceuticals.

    • Abbott tangles with Indian regulators over syrup complaint

      Abbott tangles with Indian regulators over syrup complaint

      The previously unreported case underlines the weakness of India's unwieldy and poorly resourced drug and food regulatory system, the uncertainty it creates for foreign and domestic companies operating there and the potential risk to consumers.

    • Piramal Healthcare posts Q1 net profit at Rs 89.23cr

      Piramal Healthcare posts Q1 net profit at Rs 89.23cr

      Piramal Healthcare today said it has posted a net profit of Rs 89.23 crore for the quarter ended June 30, 2011.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347